OMERACT Quality-adjusted Life-years (QALY) Working Group: Do Current QALY Measures Capture What Matters to Patients?
Fiche publication
Date publication
mars 2017
Journal
The Journal of rheumatology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr GUILLEMIN Francis
Tous les auteurs :
Trenaman L, Boonen A, Guillemin F, Hiligsmann M, Hoens A, Marra C, Taylor W, Barton J, Tugwell P, Wells G, Bansback N
Lien Pubmed
Résumé
To understand the limitations with current patient-reported outcome measures (PROM) used to generate quality-adjusted life-years (QALY) in rheumatology, and set a research agenda.
Mots clés
COST-BENEFIT ANALYSIS, OMERACT, QUALITY-ADJUSTED LIFE-YEARS, RHEUMATOLOGY
Référence
J. Rheumatol.. 2017 Mar;: